Calypte Biomedical and Maxim Biomedical Announce Joint Distribution of Incidence Testing Assays
April 25, 2013 12:00 ET
|
Calypte Biomedical Corporation
PORTLAND, Ore., April 25, 2013 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC) and Maxim Biomedical Inc. today announced a reciprocal distribution agreement under which customers may...
Calypte Biomedical Secures Funding to Conduct Clinical Trials
October 14, 2011 17:27 ET
|
Calypte Biomedical Corporation
PORTLAND, Ore., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced that it has entered into...
Calypte Biomedical Announces Successful Conclusion of Internal Trials
March 02, 2011 18:57 ET
|
Calypte Biomedical Corporation
PORTLAND, Ore., March 2, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced successful completion of...
Calypte Biomedical Awarded Therapeutic Discovery Project Grant
November 08, 2010 14:40 ET
|
Calypte Biomedical Corporation
PORTLAND, Ore., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (Pink Sheets:CBMC), the developer, manufacturer and marketer of the Aware™ HIV-1/2 OMT (oral fluid) HIV test,...